Search Orphan Drug Designations and Approvals
-
| Generic Name: | mitogen-activated protein kinase / phosphatidylinositol 3-kinase / mammalian target of rapamycin inhibitor |
|---|---|
| Date Designated: | 01/12/2024 |
| Orphan Designation: | Treatment of Myelofibrosis |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Lympharma LLC 8120 Main Street Dexter, Michigan 48130 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







